1465 related articles for article (PubMed ID: 7559897)
1. Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 levels are increased in central precocious puberty: effects of two different treatment regimens with gonadotropin-releasing hormone agonists, without or in combination with an antiandrogen (cyproterone acetate).
Juul A; Scheike T; Nielsen CT; Krabbe S; Müller J; Skakkebaek NE
J Clin Endocrinol Metab; 1995 Oct; 80(10):3059-67. PubMed ID: 7559897
[TBL] [Abstract][Full Text] [Related]
2. Serum insulin-like growth factor-I (IGF-I) and IGF binding protein-3 levels in children with precocious puberty treated with gonadotropin-releasing hormone analog without or in combination with cyproterone acetate.
Verrotti A; Ferrari M; Sabatino G; Morgese G; Chiarelli F
Gynecol Endocrinol; 1997 Aug; 11(4):243-50. PubMed ID: 9272420
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor-I and IGF binding protein-3 remain high after GnRH analogue therapy in girls with central precocious puberty.
Kanety H; Karasik A; Pariente C; Kauschansky A
Clin Endocrinol (Oxf); 1996 Jul; 45(1):7-12. PubMed ID: 8796132
[TBL] [Abstract][Full Text] [Related]
4. Irreversible increase of serum IGF-1 and IGFBP-3 levels in GnRH-dependent precocious puberty of different etiologies: implications for the onset of puberty.
Belgorosky A; Rivarola MA
Horm Res; 1998; 49(5):226-32. PubMed ID: 9568807
[TBL] [Abstract][Full Text] [Related]
5. Use of combined Gn-RH agonist and hGH therapy for better attining the goals in precocious puberty treatment.
Tatò L; Saggese G; Cavallo L; Antoniazzi F; Corrias A; Pasquino AM; Cisternino M
Horm Res; 1995; 44 Suppl 3():49-54. PubMed ID: 8719441
[TBL] [Abstract][Full Text] [Related]
6. Serum concentrations of free and total insulin-like growth factor-I, IGF binding proteins -1 and -3 and IGFBP-3 protease activity in boys with normal or precocious puberty.
Juul A; Flyvbjerg A; Frystyk J; Müller J; Skakkebaek NE
Clin Endocrinol (Oxf); 1996 May; 44(5):515-23. PubMed ID: 8762727
[TBL] [Abstract][Full Text] [Related]
7. Suppression of the pituitary-gonadal axis in children with central precocious puberty: effects on growth, growth hormone, insulin-like growth factor-I, and prolactin secretion.
Sklar CA; Rothenberg S; Blumberg D; Oberfield SE; Levine LS; David R
J Clin Endocrinol Metab; 1991 Oct; 73(4):734-8. PubMed ID: 1909701
[TBL] [Abstract][Full Text] [Related]
8. The acid-labile subunit of human ternary insulin-like growth factor-binding protein complex in girls with central precocious puberty before and during gonadotropin-releasing hormone analog therapy.
Cisternino M; Draghi M; Lauriola S; Scarcella D; Bernasconi S; Cavallo L; De Luca F; Lomeo A; Tatò L
J Clin Endocrinol Metab; 2002 Oct; 87(10):4629-33. PubMed ID: 12364447
[TBL] [Abstract][Full Text] [Related]
9. Serum concentrations of type I and III procollagen propeptides in healthy children and girls with central precocious puberty during treatment with gonadotropin-releasing hormone analog and cyproterone acetate.
Hertel NT; Stoltenberg M; Juul A; Main KM; Müller J; Nielsen CT; Lorenzen I; Skakkebaek NE
J Clin Endocrinol Metab; 1993 Apr; 76(4):924-7. PubMed ID: 8473407
[TBL] [Abstract][Full Text] [Related]
10. Serum insulin-like growth factor (IGF)-I and IGF-binding protein-3 in girls with premature thelarche.
Sales DS; Moreira AC; Camacho-Hübner C; Ricco RG; Daneluzzi JC; Campos AD; Martinelli CE
J Pediatr Endocrinol Metab; 2003; 16(6):827-33. PubMed ID: 12948294
[TBL] [Abstract][Full Text] [Related]
11. Comparison of complete and incomplete suppression of pituitary-gonadal activity in girls with central precocious puberty: influence on growth and predicted final height. The German-Dutch Precocious Puberty Study Group.
Partsch CJ; Hümmelink R; Peter M; Sippell WG; Oostdijk W; Odink RJ; Drop SL
Horm Res; 1993; 39(3-4):111-7. PubMed ID: 8262471
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Triptorelin 3-Month Depot Compared to 1-Month Depot for the Treatment of Korean Girls with Central Precocious Puberty in Single Tertiary Center.
Chung LY; Kang E; Nam HK; Rhie YJ; Lee KH
J Korean Med Sci; 2021 Aug; 36(34):e219. PubMed ID: 34463062
[TBL] [Abstract][Full Text] [Related]
13. Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty.
Boepple PA; Mansfield MJ; Wierman ME; Rudlin CR; Bode HH; Crigler JF; Crawford JD; Crowley WF
Endocr Rev; 1986 Feb; 7(1):24-33. PubMed ID: 2937629
[TBL] [Abstract][Full Text] [Related]
14. Long term treatment of male and female precocious puberty by periodic administration of a long-acting preparation of D-Trp6-luteinizing hormone-releasing hormone microcapsules.
Roger M; Chaussain JL; Berlier P; Bost M; Canlorbe P; Colle M; Francois R; Garandeau P; Lahlou N; Morel Y
J Clin Endocrinol Metab; 1986 Apr; 62(4):670-7. PubMed ID: 2936759
[TBL] [Abstract][Full Text] [Related]
15. Serum inhibin A and inhibin B in central precocious puberty before and during treatment with GnRH agonists.
Sehested A; Andersson AM; Müller J; Skakkebaek NE
Horm Res; 2000; 54(2):84-91. PubMed ID: 11251372
[TBL] [Abstract][Full Text] [Related]
16. Reproductive axis after discontinuation of gonadotropin-releasing hormone analog treatment of girls with precocious puberty: long term follow-up comparing girls with hypothalamic hamartoma to those with idiopathic precocious puberty.
Feuillan PP; Jones JV; Barnes K; Oerter-Klein K; Cutler GB
J Clin Endocrinol Metab; 1999 Jan; 84(1):44-9. PubMed ID: 9920060
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the growth hormone-insulin-like growth factor I axis in developing and adult monkeys is affected by estradiol replacement and supplementation with insulin-like growth factor I.
Wilson ME
J Clin Endocrinol Metab; 1998 Jun; 83(6):2018-28. PubMed ID: 9626134
[TBL] [Abstract][Full Text] [Related]
18. Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone analogues and growth hormone.
Pasquino AM; Pucarelli I; Segni M; Matrunola M; Cerroni F
J Clin Endocrinol Metab; 1999 Feb; 84(2):449-52. PubMed ID: 10022399
[TBL] [Abstract][Full Text] [Related]
19. Changes in growth and serum growth hormone and plasma somatomedin-C levels during suppression of gonadal sex steroid secretion in girls with central precocious puberty.
Mansfield MJ; Rudlin CR; Crigler JF; Karol KA; Crawford JD; Boepple PA; Crowley WF
J Clin Endocrinol Metab; 1988 Jan; 66(1):3-9. PubMed ID: 2961786
[TBL] [Abstract][Full Text] [Related]
20. [Comparison between complete and incomplete suppression of the hypophyseal-gonadal axis in girls with central precocious puberty: effect on growth and prospective final height].
Partsch CJ; Hümmelink R; Sippell WG; Oostdijk W; Odink RJ; Drop SL
Monatsschr Kinderheilkd; 1993 Dec; 141(12):935-9. PubMed ID: 8114776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
